Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial
Published Online: 2015-09-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Adam M Brufsky•André Robidoux•Charles E Geyer•Eleftherios P Mamounas•Francis M Senecal•Gong Tang•Harry D Bear•Howard M Gross•James A Young•Joseph P Costantino•Louis Fehrenbacher•Luis Baez-Diaz•Norman Wolmark•Paul T Adams•Priya Rastogi•Qing Liu•Rakesh Gaur•Richard G Margolese•Rita S Mehta•Sandra M Swain•Soonmyung Paik
